NCT00738985 Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors Status WITHDRAWN Phase PHASE4
NCT00723723 Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) Status COMPLETED Phase N/A
NCT00713167 The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) Status COMPLETED Phase PHASE2/PHASE3
NCT00701883 Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol Status COMPLETED Phase PHASE2
NCT00685737 Safety of a Hypolipidemic Agent in Healthy Normal Volunteers Status COMPLETED Phase PHASE1
NCT00663234 IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia Status TERMINATED Phase PHASE1/PHASE2
NCT00654459 Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function Status COMPLETED Phase N/A
NCT00652431 Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) Status COMPLETED Phase PHASE1
NCT00651560 Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148) Status COMPLETED Phase PHASE3
NCT00640549 Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus Status TERMINATED Phase PHASE4
NCT00634608 Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow Status COMPLETED Phase NA
NCT00630734 Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin Status COMPLETED Phase PHASE4
NCT00627159 ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program Status UNKNOWN Phase NA
NCT00626041 U-CHAMP: Urban Cardiovascular Health Assessment and Management Program Status UNKNOWN Phase NA